Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7293 p407
3 April 2004

This article
Reprint
Photocopy

  Acrobat Reader


News summary

Related websites
NICE: National Institute for Clinical Excellence (www.nice.org.uk)


Most GPs are over-prescribing antidepressants

More than 80 per cent of GPs admit to over-prescribing antidepressants to patients with depression, anxiety and stress, a new survey reveals this week.

The doctors say that they are often forced to prescribe these drugs because appropriate psychological therapies or social care for mild to moderate mental health conditions are not available.

The survey, conducted by research company Dr Foster for Norwich Union Healthcare, also showed that nearly three-quarters of GPs say they prescribe more antidepressants now than they did five years ago. A quarter of GPs told researchers that more widespread availability of psychological therapies is one of the most pressing priorities for the NHS.

NICE guidelines

NICE guidelines on the management of depression and the management of generalised anxiety disorder and panic disorder are at the end of their consultation periods and are due to be published in June.

The draft guidelines for depression say that, although antidepressants are recommended in moderate to severe disease, they are not advised in initial treatment of mild depression. No treatment, with reassessment within a fortnight, can also be used for patients with mild depression expected to recover with no intervention. Psychological treatment such as counselling is advocated in mild to moderate depression. The guidelines for anxiety rate the long-term efficacy of cognitive behavioural therapy better than medication or self help.

Celia Feetam, clinical psychiatric pharmacist and senior teaching fellow, Aston University, Birmingham, told The Journal that these findings were reflected by prescribing trends. She added that although GPs may want to refer patients for psychological therapies, these are sparse in primary care and doctors have little option other than to prescribe medication. However, she hoped that the survey and forthcoming National Institute for Clinical Excellence guidelines (see Panel) would increase the impetus for more funding for psychological help from suitably trained staff.

She added that pharmacists may be able to help by making patients aware of non-pharmacological strategies for the treatment of depression and anxiety, especially if patients are not taking their prescribed medicines. Patients wanting other services should demand them from their primary care trusts, she said.

Although medication could help with biological effects, such as appetite and sleep loss, in depression caused by life events, patients often needed long-term coping skills, she explained.

Norwich Union says that its study also showed that a third of people interviewed claimed to know someone, or were themselves, suffering from a mild or moderate mental health condition. Seventeen per cent had sought help or advice from a health care professional for mild anxiety, depression or stress. The company has launched an online resource explaining mental health conditions and their therapies with a guide to health service provision by postcode or specialty (www.personalhealthmanager.co.uk).

Back to Top


©The Pharmaceutical Journal